| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of Rare Disease | Chief Commercial Officer
1 company
Mutz Christopher is a Head Of Rare Disease at ANIP. Recent filings cover 0 purchases and 11 sales. Those positions are worth an estimated $6.5M at current prices.
Our model assigns Mutz Christopher a below-average insider score of 44/100, based on 6 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -17.0%.
Mutz Christopher's largest disclosed position is in ANIP as Head Of Rare Disease, worth about $6.5M. The recent filings there lean toward selling, a net 42,157 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 3,162 | $71.64 | $226,525.68 | -3.3% | +15.8% | - | |
| Mar 9, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 5,723 | $74.19 | $424,616.98 | -5.7% | +7.1% | - | |
| Mar 2, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 417 | $74.00 | $30,858.00 | -0.4% | +2.0% | - | |
| Feb 20, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 5,323 | $78.02 | $415,300.46 | -5.9% | +6.4% | - | |
| Feb 12, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 7,032 | $76.55 | $538,299.60 | -7.1% | +5.4% | - | |
| May 14, 2025 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 4,000 | $60.45 | $241,800.00 | -3.6% | +46.3% | +31.8% | |
| Nov 15, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 6,500 | $57.70 | $375,050.00 | -7.8% | +4.6% | +48.5% | |
| May 21, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 2,000 | $61.61 | $123,220.00 | -2.3% | -0.8% | -4.3% | |
| Mar 5, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 5,000 | $66.00 | $330,000.00 | -5.4% | -2.9% | -8.7% | |
| Nov 10, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 3,000 | $52.47 | $157,410.00 | -4.5% | +7.2% | +17.8% |